What Are the Challenges in Using Immune Checkpoint Inhibitors?
Despite their potential, immune checkpoint inhibitors are not universally effective. Challenges include identifying patients who will benefit the most, managing side effects, and understanding mechanisms of resistance that some tumors develop. Ongoing research aims to address these challenges and improve the efficacy and safety of these therapies.
